RU2735542C2 - Применение растворимого cd146 в качестве биомаркера для селекции оплодотворенного in vitro эмбриона для имплантации млекопитающему - Google Patents

Применение растворимого cd146 в качестве биомаркера для селекции оплодотворенного in vitro эмбриона для имплантации млекопитающему Download PDF

Info

Publication number
RU2735542C2
RU2735542C2 RU2017140204A RU2017140204A RU2735542C2 RU 2735542 C2 RU2735542 C2 RU 2735542C2 RU 2017140204 A RU2017140204 A RU 2017140204A RU 2017140204 A RU2017140204 A RU 2017140204A RU 2735542 C2 RU2735542 C2 RU 2735542C2
Authority
RU
Russia
Prior art keywords
embryo
scd146
concentration
implantation
culture medium
Prior art date
Application number
RU2017140204A
Other languages
English (en)
Russian (ru)
Other versions
RU2017140204A (ru
RU2017140204A3 (zh
Inventor
Натали БАРДЕН
Марсель БЛО-ШАБО
Сильви БУВЬЕ
Одиль ЛАКРУА
Франсуаз ДИНЬА-ЖОРЖ
Жан-Кристоф Раймон ГРИ
Original Assignee
Юниверсите Д'Экс-Марсель
Энсэрм (Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль)
Юниверсите Де Монпелье
Сантр Оспиталье Юниверситер Де Ним
Ассистанс Пюблик Опито Де Марсель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юниверсите Д'Экс-Марсель, Энсэрм (Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль), Юниверсите Де Монпелье, Сантр Оспиталье Юниверситер Де Ним, Ассистанс Пюблик Опито Де Марсель filed Critical Юниверсите Д'Экс-Марсель
Publication of RU2017140204A publication Critical patent/RU2017140204A/ru
Publication of RU2017140204A3 publication Critical patent/RU2017140204A3/ru
Application granted granted Critical
Publication of RU2735542C2 publication Critical patent/RU2735542C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RU2017140204A 2015-04-21 2016-04-21 Применение растворимого cd146 в качестве биомаркера для селекции оплодотворенного in vitro эмбриона для имплантации млекопитающему RU2735542C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305596.7 2015-04-21
EP15305596 2015-04-21
PCT/EP2016/058825 WO2016170021A1 (en) 2015-04-21 2016-04-21 Use of soluble cd146 as a biomarker to select in vitro-fertilized embryo for implantation in a mammal

Publications (3)

Publication Number Publication Date
RU2017140204A RU2017140204A (ru) 2019-05-21
RU2017140204A3 RU2017140204A3 (zh) 2019-10-14
RU2735542C2 true RU2735542C2 (ru) 2020-11-03

Family

ID=52998005

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017140204A RU2735542C2 (ru) 2015-04-21 2016-04-21 Применение растворимого cd146 в качестве биомаркера для селекции оплодотворенного in vitro эмбриона для имплантации млекопитающему

Country Status (10)

Country Link
US (1) US10809269B2 (zh)
EP (1) EP3286566B1 (zh)
JP (1) JP6751104B2 (zh)
CN (1) CN107636467B (zh)
BR (1) BR112017022710A2 (zh)
CA (1) CA2983365A1 (zh)
DK (1) DK3286566T3 (zh)
ES (1) ES2741854T3 (zh)
RU (1) RU2735542C2 (zh)
WO (1) WO2016170021A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7550434B2 (ja) 2019-05-13 2024-09-13 国立大学法人宇都宮大学 体外における哺乳動物胚を選別する方法
AU2021418225A1 (en) 2021-01-05 2023-07-13 Public University Corporation Yokohama City University Biomarker for determining fertility, and determining method using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795820A1 (fr) * 1999-07-01 2001-01-05 Biocytex Procede de quantification de microparticules endotheliales
EP1944611A1 (en) * 2007-01-11 2008-07-16 Université de la Méditerranée Biomarker for the medicine and the biology of the reproduction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245101B (zh) * 2008-01-31 2013-10-16 中国科学院生物物理研究所 抗人cd146的单克隆抗体，包含其的组合物，检测可溶性cd146的方法
US7943293B2 (en) * 2008-05-28 2011-05-17 Genx International, Inc. Media solutions and methods for cryopreservation and thawing of in vitro fertilization specimens
EP2216399A1 (en) * 2009-01-30 2010-08-11 Université de la Méditerranée Human soluble CD146, preparation and uses thereof
WO2012052433A1 (en) * 2010-10-18 2012-04-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
JP2014193145A (ja) * 2013-03-01 2014-10-09 Naoki Yamashita 胚盤胞培養液中のノルエピネフリン量によるヒト胚盤胞の評価方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795820A1 (fr) * 1999-07-01 2001-01-05 Biocytex Procede de quantification de microparticules endotheliales
EP1944611A1 (en) * 2007-01-11 2008-07-16 Université de la Méditerranée Biomarker for the medicine and the biology of the reproduction

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Kaspi E et al. Soluble CD146 and APS: a potential biomarker of obstetrical complications? // Lupus. 2012 Jun; 21(7):779-780. *
Kaspi E et al. Soluble CD146 and APS: a potential biomarker of obstetrical complications? // Lupus. 2012 Jun; 21(7):779-80. Shih IM et al. The role of CD146 (Mel-CAM) in biology and pathology //J Pathol. 1999 Sep; 189(1):4-11. *
Kaspi E. et al. Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development // Angiogenesis. 2013 Apr; 16(2):329-342. *
Kaspi E. et al. Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development // Angiogenesis. 2013 Apr; 16(2):329-42. *
Shih IM et al. The role of CD146 (Mel-CAM) in biology and pathology //J Pathol. 1999 Sep; 189(1):4-11. *

Also Published As

Publication number Publication date
ES2741854T3 (es) 2020-02-12
WO2016170021A1 (en) 2016-10-27
CN107636467A (zh) 2018-01-26
US20180164323A1 (en) 2018-06-14
EP3286566B1 (en) 2019-07-03
CN107636467B (zh) 2019-08-06
RU2017140204A (ru) 2019-05-21
DK3286566T3 (da) 2019-08-26
CA2983365A1 (en) 2016-10-27
JP2018513979A (ja) 2018-05-31
BR112017022710A2 (pt) 2018-07-17
US10809269B2 (en) 2020-10-20
JP6751104B2 (ja) 2020-09-02
EP3286566A1 (en) 2018-02-28
RU2017140204A3 (zh) 2019-10-14

Similar Documents

Publication Publication Date Title
Lee et al. The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age
Quenby et al. Different types of recurrent miscarriage are associated with varying patterns of adhesion molecule expression in endometrium
JP2010515909A (ja) 生殖の医学および生物学のためのバイオマーカー
Westergaard et al. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles.
WO2007125317A1 (en) Fertility test based on measuring inhibin b, amh, and fsh
Treetampinich et al. Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome
Sacha et al. Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center
RU2735542C2 (ru) Применение растворимого cd146 в качестве биомаркера для селекции оплодотворенного in vitro эмбриона для имплантации млекопитающему
Dalcik et al. Expression of insulin-like growth factor in the placenta of intrauterine growth-retarded human fetuses
Tavmergen et al. Value of serum CA-125 concentrations as predictors of pregnancy in assisted reproduction cycles
Ramer et al. The serum brain-derived neurotrophic factor concentration prior to initiation of an in vitro fertilization cycle predicts outcome
Chuan et al. Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization
EP3803411A1 (en) Methods for diagnosing fertility of ejaculates for artificial insemination
Shen et al. Effect of BMI on the value of serum progesterone to predict clinical pregnancy outcome in IVF/ICSI cycles: a retrospective cohort study
JP2002519640A (ja) 未受精卵の存在を示すためのアッセイ
Westergaard et al. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI
Lee et al. Attachment of a trophoblastic spheroid onto endometrial epithelial cells predicts cumulative live birth in women aged 35 and older
JP5828195B2 (ja) 妊娠損失リスクを予測する方法および妊娠損失リスクを低下させる方法
EP3356830B1 (en) A method of treatment and prognosis
JP2013522603A5 (zh)
Mohammed et al. Relationship Between Anti-Mullerian Hormone (AMH) and Other Influencing Factors with in Vitro Fertilization (IVF) Outcome of Iraqi Infertile Women
Kzar et al. Early Serum Progesterone Measurement on 9th Day after Oocyte Retrieval can be used as a Predictor of Fresh Intracytoplasmic Sperm Injection Cycle Success
Ali et al. Correlation between resistin and follistatin hormones with pregnancy outcome in samples of Iraqi women undergoing ICSI cycle
Ibis et al. Testicular sperm retrieval for intracytoplasmic sperm injection: when to consider it after unsuccessful intracytoplasmic sperm injection with ejaculated sperm?
Xie et al. Effect of anti‐Müllerian hormone on early pregnancy loss in hormone replacement therapy–frozen–thawed embryo transfer cycles: An analysis including 6597 pregnant patients undergoing their first in vitro fertilization/intracytoplasmic sperm injection cycle